Skip to content

Latest medicine updates

134 updates found

New New Updated Updated Retired Retired

NARROW IT DOWN

MEDICINE NAME

CHANGES

Date range

DOCUMENT TYPE

STATUS

SPC
zolpidem tartrate
Updated 23-Jun-17
Updated
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text
SPC
D-GAM, Solution for Injection 250iu vials
human anti-d immunoglobulin
Retired 23-Jun-17
Bio Products Laboratory Limited
Retired
  • Licence withdrawn
SPC
Nurofen 5% gel
ibuprofen
Retired 23-Jun-17
Reckitt Benckiser Healthcare (UK) Ltd
Retired
  • Product/presentation currently not marketed
Pil
Nurofen 5% Gel
ibuprofen
Retired 23-Jun-17
Reckitt Benckiser Healthcare (UK) Ltd
Retired
  • Product/presentation currently not marketed
Pil
prednisolone acetate
Updated 23-Jun-17
Updated
  • Change to section 6 - date of revision
  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - manufacturer
Pil
adalimumab
Updated 23-Jun-17
Updated
  • Change to section 6 - date of revision
  • Change to other sources of information section
SPC
esomeprazole sodium
Updated 23-Jun-17
Updated
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.7 - Effects on ability to drive and use machines
  • Change to section 4.8 - Undesirable effects
  • Change to section 6.2 - Incompatibilities
  • Change to section 6.6 - Special precautions for disposal and other handling
  • Change to section 10 - Date of revision of the text
Pil
alfuzosin hydrochloride
Updated 23-Jun-17
Updated
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
Pil
alfuzosin hydrochloride
Updated 23-Jun-17
Updated
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
Pil
sodium valproate
Updated 23-Jun-17
Updated
  • Change to section 6 - what the product looks like and pack contents
Pil
rotigotine
Updated 23-Jun-17
Updated
  • Change to section 6 - what the product looks like and pack contents
  • Change to section 3 - how to take/use
Pil
rotigotine
Updated 23-Jun-17
Updated
  • Change to section 6 - what the product looks like and pack contents
  • Change to section 3 - how to take/use
Pil
rotigotine
Updated 23-Jun-17
Updated
  • Change to section 6 - what the product looks like and pack contents
  • Change to section 3 - how to take/use
Pil
rotigotine
Updated 23-Jun-17
Updated
  • Change to section 6 - what the product looks like and pack contents
  • Change to section 3 - how to take/use
Pil
rotigotine
Updated 23-Jun-17
Updated
  • Change to section 6 - what the product looks like and pack contents
  • Change to section 3 - how to take/use
SPC
tramadol hydrochloride
Updated 23-Jun-17
Updated
  • Change to section 4.8 - Undesirable effects
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 10 - Date of revision of the text
SPC
atenolol
Updated 23-Jun-17
Updated
  • Change to section 4.1 - Therapeutic indications
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Fertility, pregnancy and lactation
  • Change to section 4.8 - Undesirable effects
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 10 - Date of revision of the text
SPC
atenolol
Updated 23-Jun-17
Updated
  • Change to section 4.1 - Therapeutic indications
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Fertility, pregnancy and lactation
  • Change to section 4.8 - Undesirable effects
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 10 - Date of revision of the text
SPC
atenolol
Updated 23-Jun-17
Updated
  • Change to section 4.1 - Therapeutic indications
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Fertility, pregnancy and lactation
  • Change to section 4.8 - Undesirable effects
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 10 - Date of revision of the text
SPC
paracetamol, phenylephrine hydrochloride
Updated 23-Jun-17
Updated
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 6.1 - List of excipients
  • Change to section 10 - Date of revision of the text
SPC
phenytoin
Updated 23-Jun-17
Updated
  • Change to section 4.8 - Undesirable effects
  • Change to section 4.8 - Undesirable effects - how to report a side effect
SPC
phenytoin
Updated 23-Jun-17
Updated
  • Change to section 4.8 - Undesirable effects
  • Change to section 4.8 - Undesirable effects - how to report a side effect
SPC
phenytoin sodium
Updated 23-Jun-17
Updated
  • Change to section 4.8 - Undesirable effects
  • Change to section 4.8 - Undesirable effects - how to report a side effect
SPC
glycerol
Updated 23-Jun-17
Updated
  • Change to section 6.3 - Shelf life
  • Change to section 10 - Date of revision of the text
SPC
levothyroxine sodium
Updated 23-Jun-17
Updated
  • Change to section 4.2 - Posology and method of administration
Pil
sodium valproate
Updated 23-Jun-17
Updated
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - what you need to know - contraindications
  • Change to section 4 - possible side effects
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 6 - date of revision
Pil
Cinryze 500 Units powder and solvent for solution for injection
C1 inhibitor (human)
Retired 23-Jun-17
Shire Pharmaceuticals Limited
Retired
  • Retired pending re-submission
Pil
sodium valproate
Updated 23-Jun-17
Updated
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - what you need to know - contraindications
  • Change to section 4 - possible side effects
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 6 - date of revision
Pil
granisetron hydrochloride
Updated 23-Jun-17
Updated
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 6 - date of revision
Pil
denosumab
Updated 23-Jun-17
Updated
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
SPC
albiglutide
Updated 23-Jun-17
Updated
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 10 - Date of revision of the text
SPC
paracetamol, diphenhydramine hydrochloride
Updated 23-Jun-17
Updated
  • Change to section 4.2 - Posology and method of administration
  • Change to section 10 - Date of revision of the text
SPC
paracetamol
Updated 23-Jun-17
Updated
  • Change to section 4.2 - Posology and method of administration
  • Change to section 10 - Date of revision of the text
SPC
paracetamol
Updated 23-Jun-17
Updated
  • Change to section 4.2 - Posology and method of administration
  • Change to section 10 - Date of revision of the text
Pil
aluminium hydroxide, magnesium hydroxide
Updated 23-Jun-17
New
  • New PIL for new product
Pil
esomeprazole magnesium trihydrate
Updated 22-Jun-17
New
  • New PIL for new product
Pil
paracetamol
Updated 22-Jun-17
Updated
  • Change to section 3 - use in children/adolescents
  • Change to section 3 - how to take/use
  • Change to section 6 - date of revision
Pil
paracetamol, diphenhydramine hydrochloride
Updated 22-Jun-17
Updated
  • Change to section 3 - use in children/adolescents
  • Change to section 3 - how to take/use
  • Change to section 6 - date of revision
Pil
paracetamol
Updated 22-Jun-17
Updated
  • Change to section 3 - use in children/adolescents
  • Change to section 3 - how to take/use
  • Change to section 6 - date of revision
SPC
Maalox Suspension
aluminium hydroxide gel, magnesium hydroxide
Retired 22-Jun-17
SANOFI
Retired
  • Product/presentation discontinued
Pil
Maalox Suspension
aluminium hydroxide gel, magnesium hydroxide
Retired 22-Jun-17
SANOFI
Retired
  • Product/presentation discontinued
Pil
filgrastim
Updated 22-Jun-17
Updated
  • Change to section 6 - manufacturer
  • Change to section 6 - date of revision
SPC
sofosbuvir, ledipasvir
Updated 22-Jun-17
Updated
  • Change to section 4.8 - Undesirable effects
Pil
atenolol
Updated 22-Jun-17
Updated
  • Change to section 2 - what you need to know - contraindications
  • Change to section 4 - possible side effects
  • Change to section 6 - what the product contains
  • Change to section 6 - date of revision
SPC
atenolol
Updated 22-Jun-17
Updated
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 3 - Pharmaceutical form
  • Change to section 4.2 - Posology and method of administration
  • Change to section 6.1 - List of excipients
  • Change to section 6.5 - Nature and contents of container
  • Change to section 10 - Date of revision of the text
SPC
atenolol
Updated 22-Jun-17
Updated
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 3 - Pharmaceutical form
  • Change to section 4.2 - Posology and method of administration
  • Change to section 6.1 - List of excipients
  • Change to section 6.5 - Nature and contents of container
  • Change to section 10 - Date of revision of the text
SPC
oxaliplatin
Updated 22-Jun-17
Updated
  • Change to legal category
  • Addition of legal category
SPC
esomeprazole magnesium trihydrate
Updated 22-Jun-17
Updated
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.7 - Effects on ability to drive and use machines
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text
SPC
esomeprazole magnesium trihydrate
Updated 22-Jun-17
Updated
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.7 - Effects on ability to drive and use machines
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text
SPC
esomeprazole magnesium trihydrate
Updated 22-Jun-17
Updated
  • Change to section 4.7 - Effects on ability to drive and use machines
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text

Page 1 of 3 Next

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue